Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07401316 · ClinicalTrials.gov registry record · NA
Circulating Tumor DNA in Stage I, II, and III Germ-Cell Tumors
A NA study, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT07401316: Recruiting NA study, sponsored by Indiana University.
NCT07401316 is a NA study that is actively recruiting participants, run by Indiana University. The registered enrollment target is 130 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07401316, a NA study, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
This study will evaluate the utility of ctDNA detection in patients with high-risk stage I, stage II, and stage III germ cell tumor disease to develop a tool for post-treatment cancer cell detection.
Primary Outcome
PPV will be calculated as the number of true positives divided by the total number of positive tests in patients with high-risk stage I germ cell tumor.
Interventions
- DIAGNOSTIC_TEST Whole blood for ctDNA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2026-06-03 |
| Est. Completion | 2032-12 |
| Phase | NA |
What NCT07401316 shows while recruiting
NCT07401316 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which Whole blood for ctDNA is the first listed.
NCT07401316 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07401316 about?
NCT07401316 is a clinical study titled "Circulating Tumor DNA in Stage I, II, and III Germ-Cell Tumors". This study will evaluate the utility of ctDNA detection in patients with high-risk stage I, stage II, and stage III germ cell tumor disease to develop a tool for post-treatment cancer cell detection.
What is the current status of trial NCT07401316?
This trial is currently recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2026-06-03. Estimated completion is 2032-12.
What interventions are being tested in trial NCT07401316?
The interventions under investigation include: Whole blood for ctDNA (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07401316?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07401316's enrollment target sits among peer trials
130 733rd of 2000 higher than 1,257 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI